Sensitivity for lymph node metastasis was 50% (95% CI, 9%-91%) and 25% (95% CI, 1%-78%) for PSMA PET and MRI, respectively. Here, FOLH1 is linked to metastatic malignant neoplasm in the lymph nodes.